EMvision Medical Devices (ASX:EMV) Net Margin %: 0.00% (As of Dec. 2025)


ASX:EMV EMvision Medical Devices Ltd ASX:EMV
33 GF Score
Price A$1.48
! 3 Warning Signs
View Full Analysis

What is EMvision Medical Devices Net Margin %?

EMvision Medical Devices ASX:EMV -2.95% 33 Net Margin % is 0.00% as of Dec. 2025. GuruFocus rates ASX:EMV with a GF Score™ of 33/100. The stock has 3 warning signs investors should review. Among 817 Medical Devices & Instruments companies, EMvision Medical Devices ranks worse than 122398.9% on this metric.

Net margin is calculated as Net Income divided by its Revenue. EMvision Medical Devices's Net Income for the six months ended in Dec. 2025 was A$-3.97 Mil. EMvision Medical Devices's Revenue for the six months ended in Dec. 2025 was A$0.00 Mil. Therefore, EMvision Medical Devices's net margin for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for EMvision Medical Devices's Net Margin % or its related term are showing as below:


ASX:EMV's Net Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.07
* Ranked among companies with meaningful Net Margin % only.

EMvision Medical Devices  (ASX:EMV) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

EMvision Medical Devices Net Margin % Related Terms

EMvision Medical Devices Net Margin % Historical Data

* Premium members only.

The historical data trend for EMvision Medical Devices's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EMvision Medical Devices Net Margin % Chart

EMvision Medical Devices Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Net Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

EMvision Medical Devices Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ASX:EMV vs ABT, SYK, MDT: Net Margin % Comparison

For the Medical Devices subindustry, EMvision Medical Devices's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EMvision Medical Devices Net Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, EMvision Medical Devices's Net Margin % distribution charts can be found below:

* The bar in red indicates where EMvision Medical Devices's Net Margin % falls into.


ASX:EMV
33GF Score
EMvision Medical Devices Ltd ASX:EMV
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EMvision Medical Devices Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

EMvision Medical Devices's Net Margin for the fiscal year that ended in Jun. 2025 is calculated as

Net Margin=Net Income (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-9.806/0
= %

EMvision Medical Devices's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-3.968/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
EMvision Medical Devices (ASX:EMV) has a Net Margin % of 0.00% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on EMvision Medical Devices and its competitors. According to the industry distribution chart, EMvision Medical Devices ranks #999999 out of 817 companies in the Medical Devices & Instruments industry.
Is EMvision Medical Devices' Net Margin % too high?
EMvision Medical Devices' current Net Margin % is 0.00%. Based on the distribution chart, EMvision Medical Devices ranks #999999 out of 817 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, EMvision Medical Devices has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does EMvision Medical Devices' Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EMvision Medical Devices ranks #999999 out of 817 companies for Net Margin %. This places EMvision Medical Devices in the lower half of its industry. The industry median Net Margin % is 2.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on EMvision Medical Devices and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EMvision Medical Devices's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EMvision Medical Devices stock overvalued right now?
EMvision Medical Devices (ASX:EMV) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. EMvision Medical Devices' overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For EMvision Medical Devices (ASX:EMV), the current Net Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EMvision Medical Devices Business Description

Address 65 Epping Road, Suite 4.01, Macquarie Park, Sydney, NSW, AUS, 2113
EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research and development, and commercialisation of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. Its focus is portable, cost-effective, and non-invasive brain scanners, including a bedside device (emu) and an ultra-lightweight pre-hospital device (First Responder). Its first indication targets acute stroke care, with a second planned indication in traumatic brain injury.
33GF Score

Get the complete analysis for ASX:EMV

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.48
Price